« Back
Home /
Carglumic Acid

Carglumic Acid

Item no.	TMO-T0755-1g
Manufacturer	TargetMol
CASRN	1188-38-1
Amount	1 g
Quantity options	1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	[C@@H](CCC(O)=O)(NC(N)=O)C(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Carbaglu,N-Carbamylglutamate,N-Carbamyl-L-glutamic acid,Carbamino-L-glutamic acid,Carbamylglutamic acid,Ureidoglutaric acid
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Others
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	190.15
Description	Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
Pathways	Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0755-1g-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1 g

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question